Enteral nutrition, also known as tube feeding refers to any method of feeding that uses the gastrointestinal (GI) tract to deliver caloric requirements, including normal oral diet or liquid supplements. Nasoenteral, also known as nasogastric feeding tube is placed in the stomach through the nose, whereas a jejunostomy tube is placed directly through the skin. The tube feeding formula is used in patients suffering from chronic conditions including head trauma, cancer, and strokes. Moreover, the formula helps premature infants to gain required nutrition and medications. According to the National Center for Biotechnology Information (NCBI), nasogastric tube is most preferred method for short term feeding in the acute phase of stroke and is commonly used for providing nutrition, hydration, and essential medications.
Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1115
Rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer and neurological diseases are some of the major factors complementing growth of this market. According to the National Center for Biotechnology Information (NCBI), the prevalence of chronic disease has increased from 34.9% to 41.8% during 2004-2011. Rising number of preterm births and increasing geriatric population across the global are some of the key factors supporting growth of this market. According to the National Institutes of Health (NIH), the world’s older population is steadily growing and 8.5% of people worldwide (approximately 617 million) were recorded aging 65 and older in 2016.
Major factors propelling growth of the global enteral nutrition market are rising prevalence of chronic diseases such as diabetes, heart disease, and cancer coupled with increasing health care expenditure, worldwide. According to the American Diabetes Association (ADA), long term use of nutritional support with diabetes specific formula helps reducing chronic complications of diabetes such as cardiovascular diseases and according to the National Center for Biotechnology Information (NCBI), the use of enteral nutrition is helpful in patients with chronic heart failure (CHF). Further, according to the Office for National Statistics, in the U.K., total health care expenditure was US$ 239.92 billion in 2014, which increased by 3.6% and pegged at US$ 248.51 billion in 2015. High health care expenditure of a region depicts the affordability of the patients for expensive medical services. This in turn, is anticipated to support the overall growth of enteral nutrition market as according to NCBI, tube feeding a patient involves higher cost as compared to those without tubes. Enteral nutrition is used for patients across all age groups, however, the geriatric population segment is the most lucrative segment. Health concerns such as metabolic disorders and loss of appetite are more prevalent among the geriatric population, which is a key factor for growth of the enteral nutrition market.
Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1115
Major players operating in the global enteral nutrition market include Nestle S.A., Baxter International Inc., B. Braun Holding GmbH & Co. KG, Abbott Laboratories, Groupe Danone, Reckitt Benckiser Group Plc, Perrigo Company Plc., Meiji Seika Pharma Co. Ltd., and Fresenius Kabi AG.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154